Glioblastoma is a dangerous brain tumor known for its rapid growth and unresponsiveness to standard treatments. Investigations are constantly underway to identify new therapeutic strategies, and recently, a novel biomarker named LCA168 has emerged as a potential focus for glioblastoma treatment. LCA168 is a protein that is overexpressed in gliobla